drug
dabrafenib mesylate + trametinib dimethyl sulfoxide
Marketedupdated 2mo agoby $NVS NOVARTIS AG
Approvedcommunity read0 votes
indications
investigational
NSCLCMelanoma
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that